Ekso Bionics Holdings, Inc. - Rasio cepet EKSO

Ekso Bionics Holdings (EKSO) dominates the rehabilitative treatment segment due to clinics' low sensitivity to service costs, which is confirmed by the company's pricing evolution on GURU.Markets with a value of 1.03. Revenues are based on the sale of robotic suits for medical and industrial use. High center loyalty and FDA approval support the ecosystem, which is further fueled by inflows from military hospitals.

This indicator measures the company's ability to immediately settle short-term obligations using only cash and accounts receivable, excluding slow-moving inventories. By analyzing the quick ratio, an investor assesses the financial stability of Ekso Bionics Holdings (EKSO) amid its dependence on US insurance payments and the pace of commercial exoskeleton adoption in rehabilitation centers.